• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Necrolytic migratory erythema-like eruption associated with erlotinib in a patient with lung adenocarcinoma.

作者信息

Ma Sheng-Hsiang, Li Cheng-Yuan

机构信息

Department of Dermatology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd, Beitou District, Taipei City, 112, Taiwan, ROC; Department of Dermatology, National Yang-Ming University, No.155, Sec.2, Linong Street, Beitou District, Taipei City, 112, Taiwan, ROC.

Department of Dermatology, Taipei Veterans General Hospital, No. 201, Sec. 2, Shipai Rd, Beitou District, Taipei City, 112, Taiwan, ROC; Department of Dermatology, National Yang-Ming University, No.155, Sec.2, Linong Street, Beitou District, Taipei City, 112, Taiwan, ROC.

出版信息

Lung Cancer. 2020 Oct;148:173-174. doi: 10.1016/j.lungcan.2020.07.030. Epub 2020 Jul 31.

DOI:10.1016/j.lungcan.2020.07.030
PMID:32773208
Abstract
摘要

相似文献

1
Necrolytic migratory erythema-like eruption associated with erlotinib in a patient with lung adenocarcinoma.一名肺腺癌患者中与厄洛替尼相关的坏死性游走性红斑样皮疹
Lung Cancer. 2020 Oct;148:173-174. doi: 10.1016/j.lungcan.2020.07.030. Epub 2020 Jul 31.
2
Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.厄洛替尼诱发的反应性穿通性胶原病一例肺腺癌患者
Indian J Dermatol Venereol Leprol. 2021;87(4):548-551. doi: 10.25259/IJDVL_288_20.
3
Necrolytic migratory erythema-like eruption and paradoxical psoriasis associated with adalimumab treatment.
J Dermatol. 2021 Nov;48(11):e572-e573. doi: 10.1111/1346-8138.16140. Epub 2021 Sep 6.
4
Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer.与厄洛替尼治疗肺癌相关的肾小管间质性肾炎。
Nephrology (Carlton). 2020 Sep;25(9):730. doi: 10.1111/nep.13721. Epub 2020 May 20.
5
Necrolytic migratory erythema and glucagonoma rising from pancreatic head.坏死松解性游走性红斑和胰头起源的胰高血糖素瘤。
Pancreatology. 2013 Jul-Aug;13(4):455-7. doi: 10.1016/j.pan.2013.03.011. Epub 2013 Mar 30.
6
[A case of Sweet syndrome in a patient receiving erlotinib for lung adenocarcinoma].[1例接受厄洛替尼治疗肺腺癌患者并发Sweet综合征]
Ann Dermatol Venereol. 2020 Mar;147(3):202-206. doi: 10.1016/j.annder.2019.10.030. Epub 2020 Feb 3.
7
Erlotinib-Associated Rash Exacerbated by Whole-Brain Radiation Therapy: A Patient's Case Report.全脑放射治疗加重厄洛替尼相关皮疹：1例患者的病例报告
Pract Radiat Oncol. 2019 May;9(3):128-131. doi: 10.1016/j.prro.2018.12.007. Epub 2019 Feb 13.
8
Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient.心脏移植患者中表皮生长因子受体阳性肺腺癌的治疗
Monaldi Arch Chest Dis. 2019 May 30;89(2). doi: 10.4081/monaldi.2019.1023.
9
[Necrolytic migratory erythema in Waldmann's disease].[沃尔德曼病中的坏死性游走性红斑]
Ann Dermatol Venereol. 2006 Aug-Sep;133(8-9 Pt 1):693-6. doi: 10.1016/s0151-9638(06)70994-2.
10
Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.皮疹的给药剂量？——患者血清中厄洛替尼代谢率在寻找表皮生长因子受体（EGFR）抑制剂介导皮疹的预测生物标志物中的作用。
Eur J Cancer. 2016 Mar;55:131-9. doi: 10.1016/j.ejca.2015.11.022. Epub 2016 Jan 25.

引用本文的文献

1
The Importance and Challenges of Early Diagnosis of Paraneoplastic Skin Syndromes in Cancer Detection-A Review.副肿瘤性皮肤综合征早期诊断在癌症检测中的重要性与挑战——综述
Cancers (Basel). 2025 Mar 21;17(7):1053. doi: 10.3390/cancers17071053.